TY - JOUR
T1 - Subtype-selective activation of Kv7 channels by AaTXKβ(2-64), a novel toxin variant from the Androctonus australis Scorpion venom
AU - Landoulsi, Zied
AU - Miceli, Francesco
AU - Palmese, Angelo
AU - Amoresano, Angela
AU - Marino, Gennaro
AU - Ayeb, Mohamed El
AU - Taglialatela, Maurizio
AU - Benkhalifa, Rym
PY - 2013/11
Y1 - 2013/11
N2 - Kv7.4 channel subunits are expressed in central auditory pathways and in inner ear sensory hair cells and skeletal and smooth muscle cells. Openers of Kv7.4 channels have been suggested to improve hearing loss, systemic or pulmonary arterial hypertension, urinary incontinence, gastrointestinal and neuropsychiatric diseases, and skeletal muscle disorders. Scorpion venoms are a large source of peptides active on K+ channels. Therefore, we have optimized a combined purification/screening procedure to identify specific modulator(s) of Kv7.4 channels from the venom of the North African scorpion Androctonus australis (Aa). We report the isolation and functional characterization of AaTXKβ(2-64), a novel variant of AaTXKβ(1-64), in a high-performance liquid chromatography fraction from Aa venom (named P8), which acts as the first peptide activator of Kv7.4 channels. In particular, in both Xenopus oocytes and mammalian Chinese hamster ovary cells, AaTXKβ(2-64), but not AaTXKβ(1-64), hyperpolarized the threshold voltage of current activation and increased the maximal currents of heterologously expressed K v7.4 channels. AaTXKβ(2-64) also activated K v7.3, Kv7.2/3, and Kv7.5/3 channels, whereas homomeric Kv1.1, Kv7.1, and Kv7.2 channels were unaffected. We anticipate that these results may prove useful in unraveling the novel biologic roles of AaTXKβ(2-64)-sensitive Kv7 channels and developing novel pharmacologic tools that allow subtype-selective targeting of Kv7 channels.
AB - Kv7.4 channel subunits are expressed in central auditory pathways and in inner ear sensory hair cells and skeletal and smooth muscle cells. Openers of Kv7.4 channels have been suggested to improve hearing loss, systemic or pulmonary arterial hypertension, urinary incontinence, gastrointestinal and neuropsychiatric diseases, and skeletal muscle disorders. Scorpion venoms are a large source of peptides active on K+ channels. Therefore, we have optimized a combined purification/screening procedure to identify specific modulator(s) of Kv7.4 channels from the venom of the North African scorpion Androctonus australis (Aa). We report the isolation and functional characterization of AaTXKβ(2-64), a novel variant of AaTXKβ(1-64), in a high-performance liquid chromatography fraction from Aa venom (named P8), which acts as the first peptide activator of Kv7.4 channels. In particular, in both Xenopus oocytes and mammalian Chinese hamster ovary cells, AaTXKβ(2-64), but not AaTXKβ(1-64), hyperpolarized the threshold voltage of current activation and increased the maximal currents of heterologously expressed K v7.4 channels. AaTXKβ(2-64) also activated K v7.3, Kv7.2/3, and Kv7.5/3 channels, whereas homomeric Kv1.1, Kv7.1, and Kv7.2 channels were unaffected. We anticipate that these results may prove useful in unraveling the novel biologic roles of AaTXKβ(2-64)-sensitive Kv7 channels and developing novel pharmacologic tools that allow subtype-selective targeting of Kv7 channels.
UR - http://www.scopus.com/inward/record.url?scp=84885988856&partnerID=8YFLogxK
U2 - 10.1124/mol.113.088971
DO - 10.1124/mol.113.088971
M3 - Article
C2 - 24019223
AN - SCOPUS:84885988856
SN - 0026-895X
VL - 84
SP - 763
EP - 773
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 5
ER -